Clinical Trials · NCT06085976

Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.

UnknownPhase 2Octreotide (Unclear)
Phase
Phase 2
Recruitment status
Unknown
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Enrollment
62
Start date
Aug 2023
Locations
1 site, Spain
Primary endpoint
Incidence on intraoperative bleeding.
View Octreotide compound reference